Soleus Capital Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-400,000
Closed -$880K 117
2025
Q4
$880K Sell
400,000
-2,100,000
-84% -$3.38M 0.03% 86
2025
Q3
$3.98M Buy
+2,500,000
New +$3.24M 0.2% 64

Other funds holding GUTS

Soleus Capital Management's GUTS Position: Q1 2026 in Review

Soleus Capital Management sold out of Fractyl Health (GUTS) in Q1 2026, closing a stake of 400,000 shares — an estimated $880K sold.

Soleus Capital Management first reported a position in GUTS in Q3 2025 and held it in 2 quarters. The position peaked at $3.98M in Q3 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Soleus Capital Management reported no remaining Fractyl Health position as of Q1 2026 after selling out during the quarter.
  • Soleus Capital Management sold 400,000 Fractyl Health shares in Q1 2026, an estimated $880K.
  • Soleus Capital Management first reported a position in Fractyl Health in Q3 2025 and held it in 2 quarters.
  • Soleus Capital Management's Fractyl Health position peaked at $3.98M in Q3 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.